Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Carotenuto, Marianeve ^a,b   Pedone, Emilia ^c   Diana, Donatella ^c   De Antonellis, Pasqualino ^a,b   Džeroski, Sašo ^f   Marino, Natascia ^a,m   Navas, Luigi ^b   Di Dato, Valeria ^a,b   Scoppettuolo, Maria Nunzia ^a,b   Cimmino, Flora ^a,b   Correale, Stefania ^c   Pirone, Luciano ^l   Monti, Simona Maria ^c   Bruder, Elisabeth ^e   Ženko, Bernard ^f   Slavkov, Ivica ^f   Pastorino, Fabio ^g   Ponzoni, Mirco ^g   Schulte, Johannes H ^h   Schramm, Alexander ^h   Eggert, Angelika ^h   Westermann, Frank ⁱ   Arrigoni, Gianluigi ^j   Accordi, Benedetta ^k   Basso, Giuseppe ^k   Saviano, Michele ^l   Fattorusso, Roberto ^c,d   Zollo, Massimo ^a,b   more..

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF BASEL   (Switzerland)

^f JO EF STEFAN INSTITUTE   (Slovenia)

^g G GASLINI INSTITUTE   (Italy)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j SAN RAFFAELE HOSPITAL   (Italy)

^k UNIVERSITY OF PADOVA   (Italy)

^l CNR   (Italy)

^m NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PEPTIDE; PRUNE PROTEIN, HUMAN;

ANIMAL; ARTICLE; BINDING SITE; CELL MOTION; CELL STRAIN HEK293; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MOUSE; MUTATION; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE MOUSE; PATHOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BINDING SITES; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, NUDE; MODELS, MOLECULAR; MUTATION; NEOPLASM METASTASIS; NEUROBLASTOMA; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875161184     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01351     Document Type: Article

References (45)

1. Brodeur, G. M. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 11, 1466-1477 (1993). (Pubitemid 23228250)
2. Breslow, N. & McCann, B. Statistical estimation of prognosis for children with neuroblastoma. Cancer research 31, 2098-2103 (1971).
3. Shimada, H. et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92, 2451-2461 (2001). (Pubitemid 33029092)
4. Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. The New England journal of medicine 313, 1111-1116 (1985). (Pubitemid 16216827)
5. Look, A. T. et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 9, 581-591 (1991).
6. Abel, F. et al. A 6-gene signature identifies four molecular subgroups of neuroblastoma. Cancer cell international 11, 9 (2011).
7. De Preter, K. et al.Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds. Clinical cancer research: an official journal of the American Association for Cancer Research 15, 3690-3696 (2009).
8. Diskin, S. J. et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nature genetics (2012).
9. Fieuw, A. et al. Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas. International journal of cancer. Journal international du cancer 130, 2599-2606 (2012).
10. Schramm, A. et al. Next-generation RNA sequencing reveals differential expression ofMYCNtarget genes and suggests themTORpathway as a promising therapy target in MYCN-amplified neuroblastoma. International journal of cancer. Journal international du cancer (2012).
11. Theissen, J. et al. Heterogeneity of the MYCN oncogene in neuroblastoma. Clinical cancer research: an official journal of the American Association for Cancer Research 15, 2085-2090 (2009).
12. Okabe-Kado, J. et al. Clinical significance of serum NM23-H1 protein in neuroblastoma. Cancer science 96, 653-660 (2005). (Pubitemid 41723541)
13. Almgren, M. A., Henriksson, K. C., Fujimoto, J. & Chang, C. L. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Molecular cancer research: MCR 2, 387-394 (2004). (Pubitemid 39031072)
14. Garcia, I. et al. A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clinical cancer research: an official journal of the American Association for Cancer Research 18, 2012-2023 (2012).
15. Liu, F., Zhang, Y., Zhang, X. Y. & Chen, H. L. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential. Journal of cancer research and clinical oncology 128, 189-196 (2002). (Pubitemid 34280376)
16. Steeg, P. S., Bevilacqua, G., Pozzatti, R., Liotta, L. A. & Sobel, M. E. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimentalmetastasis. Cancer research 48, 6550-6554 (1988).
17. Leone, A., Flatow, U., VanHoutte, K. & Steeg, P. S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8, 2325-2333 (1993). (Pubitemid 23252360)
18. Miyazaki, H. et al. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clinical cancer research: an official journal of the American Association for Cancer Research 5, 4301-4307 (1999). (Pubitemid 30013819)
19. Leone, A. et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65, 25-35 (1991). (Pubitemid 121001210)
20. Steeg, P. S., Zollo, M. &Wieland, T. A critical evaluation of biochemical activities reported for the nucleoside diphosphate kinase/Nm23/Awd family proteins: opportunities and missteps in understanding their biological functions. Naunyn-Schmiedeberg's archives of pharmacology 384, 331-339 (2011).
21. Massidda, B. et al. Molecular alterations in key-regulator genes among patients with T4 breast carcinoma. BMC cancer 10, 458 (2010).
22. Noguchi, T. et al. h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma. Annals of surgical oncology 16, 1390-1396 (2009).
23. Oue, N. et al. Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer. Cancer science 98, 1198-1205 (2007). (Pubitemid 46993540)
24. Zollo, M. et al. Overexpression of h-prune in breast cancer is correlated with advanced disease status. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 199-205 (2005). (Pubitemid 40075796)
25. D'Angelo, A. et al. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer cell 5, 137-149 (2004). (Pubitemid 38283800)
26. D'Angelo, A. & Zollo,M. Unraveling genes and pathways influenced by H-prune PDE overexpression: a model to study cellular motility. Cell cycle 3, 758-761 (2004). (Pubitemid 40187907)
27. Spano, D. et al. Dipyridamole prevents triple-negative breast-cancer progression. Clinical & experimental metastasis (2012).
28. Tammenkoski, M. et al. Human metastasis regulator protein H-prune is a shortchain exopolyphosphatase. Biochemistry 47, 9707-9713 (2008).
29. Kobayashi, T. et al. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Molecular and cellular biology 26, 898-911 (2006). (Pubitemid 43146485)
30. Garzia, L. et al. H-prune-nm23-H1 protein complex and correlation to pathways in cancer metastasis. Journal of bioenergetics and biomembranes 38, 205-213 (2006). (Pubitemid 44962248)
31. Forus, A. et al. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene 20, 6881-6890 (2001). (Pubitemid 33054105)
32. Garzia, L. et al. Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene 27, 1853-1864 (2008). (Pubitemid 351430816)
33. Reymond, A. et al. Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene 18, 7244-7252 (1999). (Pubitemid 30032103)
34. Hatakeyama, S. TRIM proteins and cancer. Nature reviews. Cancer 11, 792-804 (2011).
35. Jiang, G. et al. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature 401, 606-610 (1999).
36. Godfried, M. B. et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21, 2097-2101 (2002). (Pubitemid 34270898)
37. Molenaar, J. J. et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nature genetics (2012).
38. Obad, S. et al. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 23, 4050-4059 (2004). (Pubitemid 38747935)
39. Zhang, X. Q. et al. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells. Oncogene 22, 6704-6716 (2003).
40. Fuchs, S. Y., Spiegelman, V. S. & Kumar, K. G. The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene 23, 2028-2036 (2004). (Pubitemid 38496732)
41. Berry, T. et al. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer cell 22, 117-130 (2012).
42. Tompa, P. On the supertertiary structure of proteins. Nature chemical biology 8, 597-600 (2012).
43. Tantos, A., Han, K. H. & Tompa, P. Intrinsic disorder in cell signaling and gene transcription. Molecular and cellular endocrinology 348, 457-465 (2012).
44. Garzia, L. et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 4, e4998 (2009).
45. de Antonellis, P. et al. MiR-34a targeting of Notch ligand delta-like 1 impairs CD151/CD1331tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS One 6, e24584 (2011).